Skip to main content
SCMR 29th Annual Scientific Sessions Main banner
Final Program


Program-At-A-Glance

Rohan Dharmakumar, PhD

Executive Director
Indiana University School of Medicine
Indianapolis, Indiana, United States

Rohan Dharmakumar earned his Bachelor of Science in Physiology and Physics, Master of Science in Mathematics and PhD in Medical Biophysics from the University of Toronto with specialization in cardiovascular physiology. He received postdoctoral training in cardiovascular MRI at the University of Toronto and then Northwestern University. In 2006, he joined the faculty in the Department of Radiology at Northwestern University and was recruited to the Department of Biomedical Science at Cedars-Sinai Medical Center in 2011 as Associate Professor. There, he held various leadership roles at the Biomedical Imaging Research Institute, including Associate Director, Director of translational cardiac imaging research and finally Co-director of PET/MRI research, a role he held since 2014. In 2018 he was promoted to Professor in the Department of Biomedical Sciences at Cedars-Sinai Medical Center, and Professor in Department of Medicine at UCLA in 2020. In 2021, he was recruited to become the inaugural Executive Director of the Krannert Cardiovascular Research Center at the Cardiovascular Institute in Indiana University School of Medicine. Under his leadership, Krannert Cardiovascular Research Center grew to more than 70-person strong, increased NIH funding from $1.1M/year to $22.4M/year within 3 years, built strong growing ties with multiple departments at IU and other neighboring institutions, increased facilities and equipment to bolster CV research across the state, and have established/ strengthened critical relationships with global industry leaders in medical device development and pharmaceuticals. In November 2024, he was appointed as the Vice Chair of Research for the Department of Radiology & Imaging Sciences. In his role as the Vice Chair of Research for Radiology & Imaging Sciences, he aspires to create a research base that embraces all aspects of science, engineering, and medicine to transform our current understanding of cardiovascular, oncologic and neurovascular diseases for developing novel diagnostics and therapeutics.

Presentation(s):